The global Inhalation CDMO Market is witnessing strong growth, with market value estimated at USD 3.8 billion in 2025 and projected to surpass USD 7.4 billion by 2036, growing at a CAGR of 6.3% during the forecast period. Increasing prevalence of respiratory diseases, rising demand for inhalation-based therapeutics, and growing pharmaceutical outsourcing activities are driving market expansion...